EUVIMEDEUVIMED entdecken
Crossref

Predictors of persistent symptoms in eosinophilic esophagitis after remission: fibrostenosis, eosinophilia, anxiety, and depression

Claire A Beveridge iD, Christina Hermanns, Shivani Thanawala iD, Arjun Chatterjee, Neha Sharma, Naga Venkata Rama Kirshna Vura, Qijun Yang, Yi Qin, Prashanthi Thota, Matthew Hoscheit, J Mark Brown, Andrei I Ivanov und 3 weitere

Diseases of the Esophagus · 2025

DOI: 10.1093/dote/doae110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Claire A Beveridge und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases Institute, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Deglutition Disorders, Chest Pain, Anxiety. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic Esophagitis (EoE) is a chronic inflammatory esophageal disorder, often associated with dysphagia, chest discomfort, and heartburn. There is limited information on persistent esophageal symptoms despite histologic remission (HR). We aimed to assess the prevalence and predictors of persistent esophageal symptoms in adult patients with EoE in HR. We performed a retrospective cohort study of adult EoE patients in HR (<15 eosinophils per high power field [eos/hpf]). Exclusion criteria included: no available data on symptoms, chronic opiate use, disorders of esophagogastric junction outflow on Chicago Classification version 4 diagnosis, esophageal candidiasis, erosive esophagitis, or other known cause of esophageal dysphagia besides EoE. Based on prior literature, definitions include: complete HR (<5 eos/hpf), partial HR (5–14 eos/hpf), and endoscopic fibrostenosis (rings and/or stricture). Esophageal symptoms were assessed within 2 weeks of HR and categorized into the major symptoms of dysphagia, chest pain, and heartburn. Given the retrospective nature of the study, a global symptom response (absence or presence) was used. Demographics, disease history, endoscopy reports, EoE endoscopic reference score, and histology were recorded. Univariate and multivariable logistic regression analyses were performed. Eosinophil thresholds for persistent symptoms were determined using receiver operating characteristics analyses. Of 289 EoE patients in HR, 133 (46%) had esophageal symptoms: dysphagia (N = 119; 41.2%), heartburn (N = 28; 20.8%), and chest pain (N = 10; 7.5%). Significant predictors for persistent dysphagia were anxiety (adjusted odds ratio [aOR] 3.77) and endoscopic fibrostenosis (aOR 3.87). Significant predictors for persistent heartburn with or without chest pain were anxiety or depression (aOR 12.2 and aOR 11.0) and partial HR (aOR 1.17 and aOR 1.18). Threshold eosinophil counts for persistent heartburn and chest pain were 2.5 and 3.5 eos/hpf, respectively (AUC 0.71 and 0.69). We report a high prevalence of persistent esophageal symptoms in EoE patients who are in HR. Risk factors include anxiety, depression, endoscopic fibrostenosis, and partial HR. These findings can help direct patient care, including endoscopic dilation and managing psychiatric comorbidities. Targeting less than 2.5 and 3.5 eos/hpf for heartburn and chest pain may be warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisDeglutition DisordersChest PainAnxietyHeartburnDepressionHumansMaleFemaleRetrospective StudiesMiddle AgedAdultRemission InductionEsophagoscopyEosinophiliaROC CurveLogistic ModelsPrevalenceEsophagusEosinophils

Stichwörter der Autor:innen

chest pain, dysphagiaheartburn

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Internal Medicine, Community Care Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Medicine, Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Medicine, Division of Hospital Medicine, University of Texas Health Science Center, San Antonio, TX, USA.
  • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

ORCID-Profile: Claire A Beveridge, Shivani Thanawala

Zitieren

APA

Beveridge, C. A., Hermanns, C., Thanawala, S., Chatterjee, A., Sharma, N., Vura, N. V. R. K., Yang, Q., Qin, Y., Thota, P., Hoscheit, M., Brown, J. M., Ivanov, A. I., Lembo, A., Gabbard, S., & Rieder, F. (2025). Predictors of persistent symptoms in eosinophilic esophagitis after remission: fibrostenosis, eosinophilia, anxiety, and depression. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae110

Vancouver

Beveridge CA, Hermanns C, Thanawala S, Chatterjee A, Sharma N, Vura NVRK, et al. Predictors of persistent symptoms in eosinophilic esophagitis after remission: fibrostenosis, eosinophilia, anxiety, and depression. Diseases of the Esophagus. 2025. doi:10.1093/dote/doae110

BibTeX
@article{Beveridge2025,
  author = {Beveridge, Claire A and Hermanns, Christina and Thanawala, Shivani and Chatterjee, Arjun and Sharma, Neha and Vura, Naga Venkata Rama Kirshna and Yang, Qijun and Qin, Yi and Thota, Prashanthi and Hoscheit, Matthew and Brown, J Mark and Ivanov, Andrei I and Lembo, Anthony and Gabbard, Scott and Rieder, Florian},
  title = {Predictors of persistent symptoms in eosinophilic esophagitis after remission: fibrostenosis, eosinophilia, anxiety, and depression},
  journal = {Diseases of the Esophagus},
  year = {2025},
  doi = {10.1093/dote/doae110}
}
Kostenlos starten →